An Eight-week Study of Saredutant and Escitalopram as Combination Treatment for Major Depressive Disorder
Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to evaluate the efficacy of saredutant 100mg once daily in
combination with escitalopram 10mg once daily compared to saredutant placebo in combination
with escitalopram 10mg once daily in patients with major depressive disorder. This study also
includes a double-placebo group (saredutant placebo in combination with escitalopram
placebo).